Literature DB >> 26649804

TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins.

Meenakshi Bhansali1, Jun Zhou1, Lirim Shemshedini1.   

Abstract

Transmembrane 4 superfamily 3 (TM4SF3) was identified as a novel androgen-regulated gene in prostate cancer (PCa) cells. Our data demonstrate that TM4SF3 exhibits androgen-induced repression of the mRNA but up-regulation of the protein. The androgen positive effect on the TM4SF3 protein is of significant interest in view of the procancer functions of both androgens and tetraspanin proteins. Androgen positively regulates TM4SF3 protein stability by inhibiting its proteasome-dependent degradation. This androgen stabilization of TM4SF3 is involved in promoting PCa cell invasion and migration of both androgen-dependent and androgen-independent PCa cells. Although confirming androgen up-regulation of the TM4SF3 protein, we observed that TM4SF3 is localized not only to the membrane, but also, surprisingly, the nuclei of PCa cells. This novel nuclear localization of TM4SF3 depends on androgen-induced nuclear localization of androgen receptor (AR) in both androgen-dependent and androgen-independent PCa cell lines. TM4SF3 interacts with AR both in PCa cell types and in vitro, strongly suggesting a direct interaction. This direct interaction is required for the stabilization of not only TM4SF3, but also remarkably AR, because down-regulation of TM4SF3 resulted in reduced AR protein levels. As expected of an important AR regulator, TM4SF3 regulates androgen-dependent gene expression in and proliferation of PCa cells. Importantly, a direct correlation between AR and TM4SF3 protein levels and nuclear colocalization were also observed in prostate tumors, strongly suggesting that the mutual stabilization resulting from the AR-TM4SF3 interaction is found in tumors and that this interaction is important in PCa biology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26649804      PMCID: PMC4695629          DOI: 10.1210/me.2015-1075

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  52 in total

1.  The phylogenetic analysis of tetraspanins projects the evolution of cell-cell interactions from unicellular to multicellular organisms.

Authors:  Shengfeng Huang; Shaochun Yuan; Meiling Dong; Jing Su; Cuiling Yu; Yang Shen; Xiaojin Xie; Yanhong Yu; Xuesong Yu; Shangwu Chen; Shicui Zhang; Pierre Pontarotti; Anlong Xu
Journal:  Genomics       Date:  2005-10-20       Impact factor: 5.736

2.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

3.  Association, mutual stabilization, and transcriptional activity of the STRA13 and MSP58 proteins.

Authors:  A V Ivanova; S V Ivanov; M L Lerman
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 4.  Tetraspanin functions and associated microdomains.

Authors:  Martin E Hemler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-10       Impact factor: 94.444

5.  Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029.

Authors:  Sabine Gesierich; Igor Berezovskiy; Eduard Ryschich; Margot Zöller
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

6.  Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.

Authors:  Sabine Gesierich; Claudia Paret; Dagmar Hildebrand; Jürgen Weitz; Kaspar Zgraggen; Friedrich H Schmitz-Winnenthal; Vaclav Horejsi; Osamu Yoshie; Dorothee Herlyn; Leonie K Ashman; Margot Zöller
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

7.  Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells.

Authors:  Richard E Sobel; Yuzhuo Wang; Marianne D Sadar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jan-Feb       Impact factor: 2.416

8.  Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.

Authors:  M E Taplin; G J Bubley; T D Shuster; M E Frantz; A E Spooner; G K Ogata; H N Keer; S P Balk
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

Review 9.  Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis.

Authors:  X Yuan; C Cai; S Chen; S Chen; Z Yu; S P Balk
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

10.  Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation.

Authors:  Luke Gaughan; Ian R Logan; David E Neal; Craig N Robson
Journal:  Nucleic Acids Res       Date:  2005-01-07       Impact factor: 16.971

View more
  4 in total

Review 1.  Non-canonical functions of claudin proteins: Beyond the regulation of cell-cell adhesions.

Authors:  Susan J Hagen
Journal:  Tissue Barriers       Date:  2017-05-19

2.  Tspan8-β-catenin positive feedback loop promotes melanoma invasion.

Authors:  Manale El Kharbili; Gweltaz Agaësse; Laetitia Barbollat-Boutrand; Roxane M Pommier; Arnaud de la Fouchardière; Lionel Larue; Julie Caramel; Alain Puisieux; Odile Berthier-Vergnes; Ingrid Masse
Journal:  Oncogene       Date:  2019-01-24       Impact factor: 9.867

3.  The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration.

Authors:  Jennifer Munkley; Urszula L McClurg; Karen E Livermore; Ingrid Ehrmann; Bridget Knight; Paul Mccullagh; John Mcgrath; Malcolm Crundwell; Lorna W Harries; Hing Y Leung; Ian G Mills; Craig N Robson; Prabhakar Rajan; David J Elliott
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

4.  Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells.

Authors:  Jun Zhou; Shuai Gao; Chen-Lin Hsieh; Mamata Malla; Lirim Shemshedini
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.